Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monophosphoryl lipid A dose-finding and safety/efficacy study in ICU patients
IRCT20170903036041N8Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, open-label trial of monophosphoryl lipid A in Healthcare-associated infection (HAI) (8 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Safety of inhaled monophosphoryl lipid A in healthy volunteers, Reduction in complications and severity of hospital-acquired infections and 1 more. Started Dec 2025; status: completed.
02
Drugs
monophosphoryl lipid A
03
Conditions
Healthcare-associated infection (HAI)
Beyond the preview
Go deeper on IRCT20170903036041N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170903036041N8.